Therascape: creation of a digital platform to predict the effect of drugs

July 6, 2016

Press Release from MedTech Strasbourg

BIONEXT, a bioinformatics company at the crossroads of IT (Information Technology) and biotechnology, has announced the creation of Therascape, a company born from BIONEXT’s expertise in bioinformatics and the acquisition of the intangible assets of Rhénovia Pharma, a key player in the biosimulation of the central nervous system (CNS) applied to the prevention and treatment of neurological, neurodegenerative and psychiatric diseases.

See more: Source